144 related articles for article (PubMed ID: 33888337)
21. Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center.
Sharabi A; Kim SS; Kato S; Sanders PD; Patel SP; Sanghvi P; Weihe E; Kurzrock R
Oncologist; 2017 Jun; 22(6):631-637. PubMed ID: 28550027
[TBL] [Abstract][Full Text] [Related]
22. HPV infection and p16
Missaoui N; Mestiri S; Bdioui A; Zahmoul T; Hamchi H; Mokni M; Hmissa S
Pathol Res Pract; 2018 Apr; 214(4):498-506. PubMed ID: 29572122
[TBL] [Abstract][Full Text] [Related]
23. Molecular Profiling and Survival of Completely Resected Primary Pulmonary Neuroendocrine Carcinoma.
Lou G; Yu X; Song Z
Clin Lung Cancer; 2017 May; 18(3):e197-e201. PubMed ID: 28024928
[TBL] [Abstract][Full Text] [Related]
24. Molecular Characterization of Neuroendocrine Carcinomas of the Endometrium: Representation in All 4 TCGA Groups.
Howitt BE; Dong F; Vivero M; Shah V; Lindeman N; Schoolmeester JK; Baltay M; MacConaill L; Sholl LM; Nucci MR; McCluggage WG
Am J Surg Pathol; 2020 Nov; 44(11):1541-1548. PubMed ID: 32773531
[TBL] [Abstract][Full Text] [Related]
25. Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma.
Shamir ER; Devine WP; Pekmezci M; Umetsu SE; Krings G; Federman S; Cho SJ; Saunders TA; Jen KY; Bergsland E; Jones K; Kim GE; Kakar S; Chiu CY; Joseph NM
Mod Pathol; 2019 Feb; 32(2):290-305. PubMed ID: 30237525
[TBL] [Abstract][Full Text] [Related]
26. Genomic characterization of small cell carcinomas of the uterine cervix.
Schultheis AM; de Bruijn I; Selenica P; Macedo GS; da Silva EM; Piscuoglio S; Jungbluth AA; Park KJ; Klimstra DS; Wardelmann E; Hartmann W; Gerharz CD; von Petersdorff M; Buettner R; Reis-Filho JS; Weigelt B
Mol Oncol; 2022 Feb; 16(4):833-845. PubMed ID: 33830625
[TBL] [Abstract][Full Text] [Related]
27. Dedifferentiation of neuroendocrine carcinoma of the uterine cervix in hypoxia.
Kubota S; Tanaka M; Endo H; Ito Y; Onuma K; Ueda Y; Kamiura S; Yoshino K; Kimura T; Kondo J; Inoue M
Biochem Biophys Res Commun; 2020 Apr; 524(2):398-404. PubMed ID: 32007268
[TBL] [Abstract][Full Text] [Related]
28. Ubiquitin C-terminal hydrolase L1 promotes lymph node metastasis in small cell neuroendocrine carcinomas of the cervix.
Zhang Y; Ding J; Zhang X; Hua K
J Int Med Res; 2022 Apr; 50(4):3000605221087620. PubMed ID: 35400238
[TBL] [Abstract][Full Text] [Related]
29. Clonal Origin and Lineage Ambiguity in Mixed Neuroendocrine Carcinoma of the Uterine Cervix.
Masuda M; Iida K; Iwabuchi S; Tanaka M; Kubota S; Uematsu H; Onuma K; Kukita Y; Kato K; Kamiura S; Nakajima A; Coppo R; Kanda M; Yoshino K; Ueda Y; Morii E; Kimura T; Kondo J; Okada-Hatakeyama M; Hashimoto S; Inoue M
Am J Pathol; 2024 Mar; 194(3):415-429. PubMed ID: 38103888
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers.
Xiang L; Li J; Jiang W; Shen X; Yang W; Wu X; Yang H
Oncotarget; 2015 Mar; 6(7):4968-75. PubMed ID: 25669975
[TBL] [Abstract][Full Text] [Related]
31.
Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
[TBL] [Abstract][Full Text] [Related]
32. ERBB2 mutation: A promising target in non-squamous cervical cancer.
Xiang L; Jiang W; Ye S; He T; Pei X; Li J; Chan DW; Ngan HYS; Li F; Tao P; Shen X; Zhou X; Wu X; Yang G; Yang H
Gynecol Oncol; 2018 Feb; 148(2):311-316. PubMed ID: 29279289
[TBL] [Abstract][Full Text] [Related]
33. Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases.
Lan-Fang L; Hai-Yan S; Zuo-Ming Y; Jian-Qing Z; Ya-Qing C
Eur J Gynaecol Oncol; 2012; 33(1):68-73. PubMed ID: 22439409
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L
Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological Aspects of Small Cell Neuroendocrine Carcinoma of the Uterine Cervix: a Multicenter Retrospective Study and Meta-Analysis.
Xu F; Ma J; Yi H; Hu H; Fan L; Wu P; Chen X; Wu X; Yu L; Xing H; Wang W
Cell Physiol Biochem; 2018; 50(3):1113-1122. PubMed ID: 30355937
[TBL] [Abstract][Full Text] [Related]
36. Neuroendocrine carcinoma of the uterine cervix: A clinicopathologic retrospective study of 31 cases with prognostic implications.
Wang KL; Yang YC; Wang TY; Chen JR; Chen TC; Chen HS; Su TH; Wang KG
J Chemother; 2006 Apr; 18(2):209-16. PubMed ID: 16736891
[TBL] [Abstract][Full Text] [Related]
37. Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis.
Cavalcanti MS; Schultheis AM; Ho C; Wang L; DeLair DF; Weigelt B; Gardner G; Lichtman SM; Hameed M; Park KJ
Int J Gynecol Pathol; 2017 Jan; 36(1):76-89. PubMed ID: 27532149
[TBL] [Abstract][Full Text] [Related]
38. High incidence of PI3K pathway gene mutations in South Indian cervical cancers.
Rose MM; Dhamodharan S; Revathidevi S; Chakkarappan SR; Jagadeesan MG; Subbiah S; Nakaoka H; Inoue I; Murugan AK; Munirajan AK
Cancer Genet; 2022 Jun; 264-265():100-108. PubMed ID: 35568000
[TBL] [Abstract][Full Text] [Related]
39. TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.
Tornesello ML; Annunziata C; Buonaguro L; Losito S; Greggi S; Buonaguro FM
J Transl Med; 2014 Sep; 12():255. PubMed ID: 25220666
[TBL] [Abstract][Full Text] [Related]
40. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
